My watch list
my.chemeurope.com  
Login  

Evonik agrees to sell its Methacrylates business

Consistent strategy execution to focus on specialty chemicals

05-Mar-2019

Evonik has signed an agreement to sell its Methacrylates business to Advent International for €3 billion. The selling price (enterprise value) is 8.5 times the business’ EBITDA. The transaction is subject to approval by the authorities in several countries and is expected to close in the third quarter of this year.

The Methacrylates business has 18 production sites and 3,900 employees worldwide. From 2016 to 2018, the business generated an average annual EBITDA of about €350 million and sales of about €1.8 billion per year. For 2019 Evonik expects sales and EBITDA at a similar level.

The transaction comprises the Methacrylates, Acrylic Products and CyPlus business lines, and some of the methacrylate resins activities. Evonik put these operations on the market as part of its systematic strategy of sharpening its focus on specialty chemicals, which are less cyclical. Private equity company Advent International is one of the most experienced financial investors in the chemical industry in the world, with more than 30 investments over three decades.

The net purchase price (equity value) can be calculated after deductions, made up primarily of pension obligations of around €500 million. Evonik will use the sale proceeds to strengthen its balance sheet and, above all, for targeted growth projects. That includes funding the purchase price of the US company PeroxyChem, which Evonik plans to close this year. In addition, some funds will be used to strengthen the present specialty chemicals portfolio, for example, by building a new polyamide 12 plant in Marl, Germany. These businesses generate an attractive margin and an above-average cash flow. Also in 2019 and even without the contribution from the Methacrylates business, Evonik will be able to cover the dividend payment out of its strong free cash flow.

Facts, background information, dossiers
  • methacrylates
More about Evonik
  • News

    Evonik reorganizes its polyamide business

    The specialty chemicals company has already begun construction of a new polyamide 12 (PA 12) facility complex and is expanding its production of transparent polyamides at the Marl Chemical Park, and, in so doing, is concentrating its activities on high-performance materials for attractive g ... more

    Evonik made a solid start to 2019

    Evonik made a solid start to the new year. Sales in the first quarter rose 1 percent to €3.29 billion compared to the prior-year quarter. Adjusted EBITDA declined 3 percent to €539 million. “In a weakening global economy we were able to hold our ground in terms of sales and earnings,” said ... more

    Evonik expands production capacities for transparent polyamides

    Due to increasing global demand for high-performance polymers, Evonik is expanding its production of transparent polyamides of the TROGAMID® CX brand at the Marl Chemical Park (Germany). Production expansion is scheduled for completion in the first quarter of 2020. The project will double t ... more

  • Job Offers

    Manager (m/f/div) Analytical Development Projects

    We don’t produce car tires, mattresses, tablets, or animal feed. However, these end products contain Evonik products – like 4,000 others, too. Often, it’s just a small amount that we contribute but that’s exactly what makes the difference. This is how Evonik makes tires more fuel-efficient, ... more

  • Companies

    Evonik Industries AG

    The Business Area Chemicals of Evonik which is active in the attractive field of specialty chemicals, holds top positions world wide. As Germany’s fifth largest power producer, Evonik is market and technology leader in the planning, construction and operation of highly efficient coal-fired ... more

    Evonik Technology & Infrastructure GmbH

    more

    Evonik Industries AG

    more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE